Education
About Us
Working with TipRanks
Follow Us
Milestone Scientific Inc (MLSS)
:MLSS
MLSS Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.38 - $1.39
Previous CloseN/A
Volume1.27M
Average Volume (3M)652.83K
Market Cap
$45.45M
Enterprise Value$68.35M
Total Cash (Recent Filing)$2.25M
Total Debt (Recent Filing)$318.70K
Price to Earnings (P/E)―
Beta0.83
Next Earnings
Nov 12, 2025EPS Estimate
-0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding78,477,320
10 Day Avg. Volume1,751,065
30 Day Avg. Volume652,833
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap1.50
Enterprise Value/Revenue7.93
Enterprise Value/Gross Profit10.67
Enterprise Value/Ebitda-9.53
Forecast
1Y Price Target
$0.88Price Target Upside51.72% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Bulls Say, Bears Say
Bulls Say
Financial HealthMilestone Scientific ended with $2.2 million in cash and no debt, indicating strong financial health.
Market ExpansionThe company plans to seek reimbursement from private payors, expanding the total available market to nine million procedures.
Medicare Market CoverageMilestone Scientific continues to make progress in the Medicare market segment for pain management with its CompuFlo System, having won coverage from three of the 12 Medicare Administrative Contractors.
Bears Say
Market Coverage LimitationsMilestone has obtained formal reimbursement from 3 of the 12 Medicare Administrative Contractors, covering about one-third of the Medicare market.
Milestone Scientific News
MLSS FAQ
What was Milestone Scientific Inc’s price range in the past 12 months?
Milestone Scientific Inc lowest stock price was $0.38 and its highest was $1.39 in the past 12 months.
What is Milestone Scientific Inc’s market cap?
Milestone Scientific Inc’s market cap is $45.45M.
When is Milestone Scientific Inc’s upcoming earnings report date?
Milestone Scientific Inc’s upcoming earnings report date is Nov 12, 2025 which is in 88 days.
How were Milestone Scientific Inc’s earnings last quarter?
Milestone Scientific Inc released its earnings results on Aug 14, 2025. The company reported -$0.02 earnings per share for the quarter, missing the consensus estimate of -$0.01 by -$0.01.
Is Milestone Scientific Inc overvalued?
According to Wall Street analysts Milestone Scientific Inc’s price is currently Undervalued.
Does Milestone Scientific Inc pay dividends?
Milestone Scientific Inc does not currently pay dividends.
What is Milestone Scientific Inc’s EPS estimate?
Milestone Scientific Inc’s EPS estimate is -0.01.
How many shares outstanding does Milestone Scientific Inc have?
Milestone Scientific Inc has 78,477,320 shares outstanding.
What happened to Milestone Scientific Inc’s price movement after its last earnings report?
Milestone Scientific Inc reported an EPS of -$0.02 in its last earnings report, missing expectations of -$0.01. Following the earnings report the stock price went down -3.333%.
Which hedge fund is a major shareholder of Milestone Scientific Inc?
Currently, no hedge funds are holding shares in MLSS
Milestone Scientific Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$0.88 (51.72% Upside)
$0.88 (51.72% Upside)
Insider Transactions
Sold Shares
Worth $296.8K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-42.67%
12-Months-Change
Fundamentals
Return on Equity
-88.36%
Trailing 12-Months
Asset Growth
-19.93%
Trailing 12-Months
Company Description
Milestone Scientific Inc
Milestone Scientific Inc. (MLSS) is a biotechnology company specializing in the development of innovative drug delivery technology and solutions. The company operates primarily in the medical device sector, focusing on the dental and obstetric markets. Milestone's core products include the CompuFlo® instrument, which utilizes patented technology for precise and controlled delivery of anesthetic agents, enhancing patient comfort and safety during procedures.
MLSS Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a generally positive outlook with significant revenue growth in the third quarter, strong gross margins, and strategic progress in the medical division with Medicare Part B alignment. However, concerns remain with the lack of revenue from China and an overall revenue decline over the nine-month period. Despite these challenges, the company seems well-positioned for future growth, particularly in international markets.View all MLSS earnings summariesMLSS Stock 12 Month Forecast
Average Price Target
$0.88
▲(51.72% Upside)
Technical Analysis
Ownership Overview
34.68% Insiders
3.81% Mutual Funds
0.08% Other Institutional Investors
58.71% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---